Symbols / TAK $16.60 -2.70% Takeda Pharmaceutical Company Limited

Healthcare • Drug Manufacturers - Specialty & Generic • Japan • NYQ
TAK Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 52.44B Enterprise Value 4.79T Income 112.93B Sales 4.46T Book/sh 15.23 Cash/sh 414.62
Dividend Yield 3.98% Payout 279.05% Employees 47455 IPO — P/E 75.45 Forward P/E 31.32
PEG 0.38 P/S 0.01 P/B 1.09 P/C — EV/EBITDA 3.76 EV/Sales 1.07
Quick Ratio 0.54 Current Ratio 1.19 Debt/Eq 70.93 LT Debt/Eq — EPS (ttm) 0.22 EPS next Y 0.53
EPS Growth 3.30% Revenue Growth 4.20% Earnings 2026-05-13 ROA 2.47% ROE 1.50% ROIC —
Gross Margin 65.53% Oper. Margin 10.85% Profit Margin 2.53% Shs Outstand 3.16B Shs Float 1.58B Short Float 0.22%
Short Ratio 2.55 Short Interest — 52W High 18.90 52W Low 12.99 Beta 0.13 Avg Volume 3.03M
Volume 2.87M Target Price $20.41 Recom Strong_buy Prev Close $17.06 Price $16.60 Change -2.70%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$3058.00
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest TAK news

No recent news from Yahoo. Try the RSS feed for latest TAK news.

Insider Transactions

No recent insider transactions.

Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category